| Ticker Details |
Pacira BioSciences, Inc.
Pacira Pharmaceuticals Inc is a specialty and generic drug manufacturing company. The company develops, manufactures, and commercializes pharmaceutical products for use in hospitals and ambulatory surgery centers across the United States.
|
| IPO Date: |
February 3, 2011 |
| Sector: |
Healthcare |
| Industry: |
Drug Manufacturers |
| Market Cap: |
$918.77M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.85 | 2.09%
|
| Avg Daily Range (30 D): |
$0.52 | 2.11%
|
| Avg Daily Range (90 D): |
$0.48 | 2.13%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.53M |
| Avg Daily Volume (30 D): |
.41M |
| Avg Daily Volume (90 D): |
.56M |
| Trade Size |
| Avg Trade Size (Sh.): |
83 |
| Avg Trade Size (Sh.) (30 D): |
52 |
| Avg Trade Size (Sh.) (90 D): |
50 |
| Institutional Trades |
| Total Institutional Trades: |
9,077 |
| Avg Institutional Trade: |
$1.78M |
| Avg Institutional Trade (30 D): |
$1.55M |
| Avg Institutional Trade (90 D): |
$1.99M |
| Avg Institutional Trade Volume: |
.04M |
| Avg Institutional Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$2.36M |
| Avg Closing Trade (30 D): |
$2.23M |
| Avg Closing Trade (90 D): |
$2.75M |
| Avg Closing Volume: |
62.8K |
|
|
| Financials |
| |
TTM |
Q4 2025 |
FY 2025 |
|
Basic EPS
|
$.16
|
$.04
|
$.16
|
|
Diluted EPS
|
$.16
|
$.04
|
$.16
|
|
Revenue
|
$726.41M
|
$196.87M
|
$726.41M
|
|
Gross Profit
|
$576.66M
|
$156.57M
|
$576.66M
|
|
Net Income / Loss
|
$7.03M
|
$1.64M
|
$7.03M
|
|
Operating Income / Loss
|
$19.19M
|
$2.34M
|
$19.19M
|
|
Cost of Revenue
|
$149.75M
|
$40.3M
|
$149.75M
|
|
Net Cash Flow
|
$-118.23M
|
$10.96M
|
$-118.23M
|
|
PE Ratio
|
|
|
|
|
|
|
